financetom
Business
financetom
/
Business
/
Market Chatter: Boeing Emphasizes Mass Production Over Safety, FAA Chief Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Boeing Emphasizes Mass Production Over Safety, FAA Chief Says
Mar 19, 2024 12:19 PM

03:00 PM EDT, 03/19/2024 (MT Newswires) -- Boeing ( BA ) culture is more inclined towards mass production over safety standards, the head of the Federal Aviation Administration told NBC News Tuesday.

Describing a series of incidents like the January door plug blowout on 737 Max jetliner as a production failure, FAA chief Michael Whitaker said Boeing ( BA ) had no other choice than to meet the 90-day deadline by the agency to outline a plan to improve the safety of its planes.

"They need to make safe airplanes or they will be capped at a production level that's not sustainable," Whitaker told the news outlet.

There was no reason the company couldn't make a good airplane, Whitaker said.

Boeing ( BA ) did not immediately respond to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 180.84, Change: +1.00, Percent Change: +0.55

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Neo Performance Material Gets Clearance for Stock Buyback, Starts Trading on OTCQX Market
Neo Performance Material Gets Clearance for Stock Buyback, Starts Trading on OTCQX Market
Jun 6, 2025
08:32 AM EDT, 06/06/2025 (MT Newswires) -- Neo Performance Materials ( NOPMF ) , which rose 3.5% on Thursday, got clearance from the Toronto Stock Exchange for a stock buyback. Under the normal course issuer bid, 3.29 million of its issued and outstanding common shares may be repurchased, representing approximately 10% of the public float of shares on May 30....
Novo Nordisk Semaglutide Vision Loss 'Very Rare' Side Effect, European Drug Agency Says
Novo Nordisk Semaglutide Vision Loss 'Very Rare' Side Effect, European Drug Agency Says
Jun 6, 2025
08:34 AM EDT, 06/06/2025 (MT Newswires) -- Novo Nordisk's ( NVO ) obesity and diabetes drug semaglutide potential to lead to a condition that may cause loss of vision is a very rare side effect, the European Medicines Agency said Friday. The drug ingredient, sold commercially as Ozempic, Rybelsus and Wegovy, can cause non-arteritic anterior ischemic optic neuropathy in up...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
BioCryst Pharmaceuticals' Hereditary Angioedema Drug Approved for Reimbursement in Netherlands
BioCryst Pharmaceuticals' Hereditary Angioedema Drug Approved for Reimbursement in Netherlands
Jun 6, 2025
08:38 AM EDT, 06/06/2025 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) said Friday its Orladeyo drug has been approved for reimbursement by the Netherlands for the routine prevention of hereditary angioedema attacks in patients aged 12 years and up. The approval followed a positive recommendation from the Zorginstituut Nederland, the company said. It means that patients and physicians across...
Copyright 2023-2026 - www.financetom.com All Rights Reserved